Dual Orexin Receptor Antagonist Sleeping Pills Research: CAGR of 7.14% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Dual Orexin Receptor Antagonist Sleeping Pills- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Dual Orexin Receptor Antagonist Sleeping Pills market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Dual Orexin Receptor Antagonist Sleeping Pills was estimated to be worth US$ 671 million in 2024 and is forecast to a readjusted size of US$ 1235 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5485211/dual-orexin-receptor-antagonist-sleeping-pills

Dual Orexin Receptor Antagonist Sleeping Pills Market Summary

Dual orexin receptor antagonists are emerging as a major therapeutic direction in modern sleep medicine, leveraging the inhibition of OX1R and OX2R pathways to restore a more physiologic pattern of sleep initiation and maintenance. Their mechanism allows sleep to occur through the natural down-regulation of wakefulness signals rather than through central nervous system suppression, resulting in sleep architecture that more closely mirrors natural patterns. Supported by steady improvements in chemical design and manufacturing capabilities, the global supply chain-spanning Europe, Japan, the United States, and China-has formed a coordinated ecosystem of API producers and formulation manufacturers. Multiple commercial products are now available in major markets, each offering differentiated pharmacokinetic properties and improved tolerability for long-term use.

Clinically, these agents are being integrated into national and regional treatment guidelines, with adoption expanding across sleep clinics, psychiatry, and primary care settings. Shifts in patient demographics, including rising chronic insomnia and aging populations, have strengthened the demand for agents with favorable safety profiles and minimal risk of dependence or withdrawal. The growing prevalence of sleep disruption associated with stress, anxiety, or mood disorders is also accelerating market uptake. Continued accumulation of long-term safety and real-world evidence by leading manufacturers has strengthened the regulatory position of DORAs, and reimbursement inclusion in several markets has further driven prescription growth and accessibility.

Looking ahead, dual orexin receptor antagonists are expected to play an expanded role in sleep disorders linked to psychiatric conditions, neurodegenerative diseases, and chronic pain, offering broader therapeutic value beyond primary insomnia. Next-generation compounds with optimized receptor selectivity, refined half-life control, and improved delivery technologies are likely to further enhance nighttime stability and minimize next-day residual effects. With increasing participation from Chinese manufacturers in API and formulation development, the global production network will become more robust and cost-competitive, supporting broader clinical adoption and positioning DORAs as a major engine of innovation and market growth in the global sleep-medicine landscape.

According to the new market research report "Global Dual Orexin Receptor Antagonist Sleeping Pills Market Report 2024-2030", published by QYResearch, the global Dual Orexin Receptor Antagonist Sleeping Pills market size is projected to grow from USD 670 million in 2024 to USD 1235 million by 2031, at a CAGR of 7.14% during the forecast period.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Dual Orexin Receptor Antagonist Sleeping Pills market is segmented as below:
By Company
Merck
Eisal
Idorsia
Simcere Pharmaceutical
Nxera Pharma

Segment by Type
Suvorexant
Lemborexant
Daridorexant

Segment by Application
Hospital and Clinic
Retail Pharmacies
Other

Each chapter of the report provides detailed information for readers to further understand the Dual Orexin Receptor Antagonist Sleeping Pills market:

Chapter 1: Introduces the report scope of the Dual Orexin Receptor Antagonist Sleeping Pills report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Dual Orexin Receptor Antagonist Sleeping Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Dual Orexin Receptor Antagonist Sleeping Pills market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Dual Orexin Receptor Antagonist Sleeping Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Dual Orexin Receptor Antagonist Sleeping Pills in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Dual Orexin Receptor Antagonist Sleeping Pills competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Dual Orexin Receptor Antagonist Sleeping Pills comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Dual Orexin Receptor Antagonist Sleeping Pills market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025
Global Dual Orexin Receptor Antagonist Sleeping Pills Market Outlook, In‐Depth Analysis & Forecast to 2031
Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.